he Greek health minister accused Roche (ROG) of blackmail after the drug maker moved to withdraw a cancer drug from the market in response to mandatory discounts imposed by the government.

As part of a bailout deal with its international lenders, such as the European Central Bank and the International Monetary Fund, the Greek government earlier this year imposed a 25 percent levy on sales generated by new patented medicines. And more recently, another 25 percent levy was added on new medicines.

This is a STAT Plus article and you can unlock it by subscribing to STAT Plus today. It's easy! Your first 30 days are free and if you don't enjoy your subscription you can cancel any time.
Already a subscriber? Log in here.

Leave a Reply to Observer079 Cancel reply

Please enter your name.
Please enter a comment.

  • Given that Novartis owns 1/3 of the voting shares in Roche [albeit ‘only 6% of the stock … somehow?], does that mean one should say another pharma is already ‘following suit’? Or not, of course ……

Sign up for our Morning Rounds newsletter

Your daily dose of what’s new in health and medicine.